Frequency News and Research

RSS

Studies reveal role of spiritual care in treating people facing serious illnesses

Two of six studies released today, reveal important advances in understanding the role of spiritual care in treating people facing serious illness, including cancer and ALS. Until now, no empirical data has existed on the contributions of chaplains in health care.

31 Mar 2014

Study compares two types of heart valve technologies

Among patients undergoing aortic valve replacement using a catheter tube, a comparison of two types of heart valve technologies, balloon-expandable or self-expandable valve systems, found a greater rate of device success with the balloon-expandable valve, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.

31 Mar 2014

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

NeuroVive's anti-viral preclinical program, with compound designated NVP018, has generated significant data indicating that NVP018 has the potential to become an effective alternative or addition to current drugs for treating chronic hepatitis B infections.

29 Mar 2014

TV watching leads to excessive snacking, cardiovascular risk in middle school kids

Middle school kids who park themselves in front of the TV for two hours or more each day are more likely to consume junk food and have risk factors for cardiovascular disease, even compared to those who spend an equal amount of time on the computer or playing video games, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

29 Mar 2014

New finding reinforces importance of developing healthy eating habits early in life

Women who ate a diet high in fresh fruits and vegetables as young adults were much less likely to have plaque build-up in their arteries 20 years later compared with those who consumed lower amounts of these foods, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

29 Mar 2014

American College of Cardiology honors two Cedars-Sinai Heart Institute researchers

Two Cedars-Sinai Heart Institute physician-researchers have been named recipients of prestigious awards from the American College of Cardiology.

28 Mar 2014

Lower levels of vitamin D predict extent of coronary artery disease

Vitamin D deficiency is an independent risk factor for heart disease with lower levels of vitamin D being associated with a higher presence and severity of coronary artery disease, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

28 Mar 2014

Research: Mediterranean diet linked to lower risk of diabetes

Adoption of a Mediterranean diet is linked to a lower risk of diabetes, especially among people at high risk for cardiovascular disease, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

27 Mar 2014

Scientists discover role of protons in neurotransmission

While probing how organisms sense gravity and acceleration, scientists at the Marine Biological Laboratory (MBL) and the University of Utah uncovered evidence that acid (proton concentration) plays a key role in communication between neurons.

27 Mar 2014

Ulcerative colitis control: an interview with Dr Paul Robinson, Medical Director, MSD UK

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD), which means there is chronic inflammation and ulceration in the lining of the digestive tract, usually in the large intestine.

26 Mar 2014

LGL Group's total revenues for Q4 2013 decrease 6.6% to $5.7 million

The LGL Group, Inc., announced results for the full year and quarter ended December 31, 2013.

25 Mar 2014

New subcellular mechanism identified for fast transmission in basket cells of the brain

In his third major research paper since December 2013, IST Austria Professor Peter Jonas together with his collaborator, postdoc Hua Hu, identifies a new subcellular mechanism for reliable, fast transmission in the so-called basket cells of the brain.

25 Mar 2014

Nightmares heighten insomnia impact on depression

Nightmares and insomnia contribute independently and additively to depression severity, cross-sectional study findings show.

24 Mar 2014

Biogen Idec's ALPROLIX gets Health Canada approval for hemophilia B

Today Biogen Idec announced that Health Canada has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B.

21 Mar 2014

Brazil's ANVISA approves Genzyme's Lemtrada for multiple sclerosis treatment

Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.

21 Mar 2014

Tooth loss associated with depression and anxiety, study finds

Today, at the 43rd Annual Meeting & Exhibition of the American Association for Dental Research, held in conjunction with the 38th Annual Meeting of the Canadian Association for Dental Research, R. Constance Wiener, from West Virginia University, Morgantown, will present a research study titled "Association of Tooth Loss and Depression and Anxiety."

21 Mar 2014

School hearing tests cannot effectively detect adolescent high-frequency hearing loss

School hearing tests cannot effectively detect adolescent high-frequency hearing loss, which is typically caused by loud noise exposure, according to researchers at Penn State College of Medicine.

21 Mar 2014

NSCLC gene fusion testing, targeted crizotinib – not yet cost effective

Genomic fusion testing for echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase genes plus targeted first-line crizotinib is not a cost effective treatment strategy for patients with advanced non-squamous non-small-cell lung cancer, shows a Canadian analysis.

20 Mar 2014

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases, today announced that preliminary top-line results of its Phase 3 clinical trial evaluating the safety and efficacy of its treatment for sickle cell anemia and sickle beta-0 thalassemia met both the primary and secondary endpoints of the clinical trial.

20 Mar 2014

Trimethoprim is more effective against streptococci than expected, says research

The focus of his team was also on samples, in which the bacteria failed to respond to the agent. They discovered two types of resistance. "Spontaneous mutations can occur in the gene for dihydrofolate reductase rendering trimethoprim no longer able to attack the changed enzyme, which means it becomes ineffective," Nitsche-Schmitz explained.

20 Mar 2014

Frequency News and Research

Studies reveal role of spiritual care in treating people facing serious illnesses

Study compares two types of heart valve technologies

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

TV watching leads to excessive snacking, cardiovascular risk in middle school kids

New finding reinforces importance of developing healthy eating habits early in life

American College of Cardiology honors two Cedars-Sinai Heart Institute researchers

Lower levels of vitamin D predict extent of coronary artery disease

Research: Mediterranean diet linked to lower risk of diabetes

Scientists discover role of protons in neurotransmission

Ulcerative colitis control: an interview with Dr Paul Robinson, Medical Director, MSD UK

LGL Group's total revenues for Q4 2013 decrease 6.6% to $5.7 million

New subcellular mechanism identified for fast transmission in basket cells of the brain

Nightmares heighten insomnia impact on depression

Biogen Idec's ALPROLIX gets Health Canada approval for hemophilia B

Brazil's ANVISA approves Genzyme's Lemtrada for multiple sclerosis treatment

Tooth loss associated with depression and anxiety, study finds

School hearing tests cannot effectively detect adolescent high-frequency hearing loss

NSCLC gene fusion testing, targeted crizotinib – not yet cost effective

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Trimethoprim is more effective against streptococci than expected, says research

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News